Securities code: Meinian Onehealth Healthcare Holdings Co.Ltd(002044) securities abbreviation: Meinian Onehealth Healthcare Holdings Co.Ltd(002044) Announcement No.: 2022028 Meinian Onehealth Healthcare Holdings Co.Ltd(002044)
Announcement on resignation of directors and by election of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Resignation of directors of the company
Meinian Onehealth Healthcare Holdings Co.Ltd(002044) (hereinafter referred to as “the company”) the board of directors today received a written resignation report from Mr. Xu panhua, a director of the company. Mr. Xu panhua applied to resign as a director of the 8th board of directors, a member of the strategy committee and the nomination committee of the board of directors due to personal work adjustment. After his resignation, Mr. Xu panhua no longer held any position in the company. Mr. Xu panhua does not hold shares in the company.
According to the company law, the articles of association and other relevant provisions, Mr. Xu panhua’s resignation will not cause the number of members of the board of directors of the company to be lower than the minimum quorum and will not affect the normal operation of the board of directors of the company. His resignation report will take effect when it is delivered to the board of directors of the company.
The company and the board of directors sincerely thank Mr. Xu panhua for his contribution to the company’s strategic development during his tenure!
2、 Information on by election of directors of the company
In order to ensure the normal work of the company’s board of directors, the company held the eighth (Interim) meeting of the eighth board of directors on March 10, 2022, deliberated and adopted the proposal on by election of non independent directors of the eighth board of directors, which was reviewed by the nomination committee of the eighth board of directors, The board of directors of the company agreed to nominate Ms. Wu Tong as a candidate for non independent director of the eighth board of directors of the company (see the attachment for resume). After being elected, Ms. Wu Tong will also serve as a member of the strategy committee and the nomination committee under the board of directors of the company. Her term of office starts from the date of deliberation and approval by the general meeting of shareholders to the expiration of the term of office of the eighth board of directors of the company. The above matters need to be submitted to the general meeting of shareholders of the company for deliberation. After the by election of non independent directors, the total number of directors who concurrently serve as senior managers of the company and staff representatives in the board of directors of the company does not exceed half of the total number of directors of the company.
The independent directors of the company have expressed their agreed independent opinions on this matter. For details, please refer to http://www.cn.info.com.cn on the same day Relevant announcements.
It is hereby announced.
Meinian Onehealth Healthcare Holdings Co.Ltd(002044) board of directors
March 10, 2002
Attachment: resume of non independent director candidates
Ms. Wu Tong:
Born in June 1988, Chinese nationality, without permanent residency abroad, obtained a bachelor’s degree from Shanghai Jiaotong University in 2009 and a master’s degree from Stanford University in 2011. From November 2013 to July 2018, he worked in Fosun Group. From July 2018 to now, he has served as the Deputy investment director of the strategic investment department of Alibaba group. As of the disclosure date of this announcement, Ms. Wu Tong did not hold shares of the company. Except for working in Alibaba group, it has no relationship with shareholders, actual controllers and other directors, supervisors and senior managers holding more than 5% of the company’s shares. Ms. Wu Tong has not been punished by the China Securities Regulatory Commission and other relevant departments or the stock exchange, nor is she a “dishonest executee”, nor is she prohibited from serving as a director of the company as stipulated in the company law and the articles of association.
